Medicine & Life Sciences
HIV-1
100%
Vaccines
91%
Macaca mulatta
75%
Vaccinia virus
69%
Natural Killer Cells
59%
T-Lymphocytes
56%
Macaca
45%
Interleukin-15
44%
ALT-803
37%
Mycobacterium bovis
34%
gp140 envelope protein, Human immunodeficiency virus 1
34%
Bacillus
31%
Atadenovirus
30%
Peptides
30%
Plasmids
26%
Replicon
26%
GP 140
25%
Memory
24%
HIV
21%
Alphavirus
21%
Cytokines
21%
Antibody Formation
19%
Myeloid Leukemia
19%
DNA Vaccines
19%
DNA
19%
Neutralizing Antibodies
17%
Electroporation
17%
B-Cell Lymphoma
16%
Lysine
15%
Sheep
14%
Semliki forest virus
13%
Vaccination
11%
Antibodies
11%
Simian Adenoviruses
11%
Anti-Bacterial Agents
10%
BCG Vaccine
10%
Safety
10%
Pediatrics
10%
Adenoviridae
9%
Acute Myeloid Leukemia
9%
Viruses
8%
Leukemia
8%
Immunotherapy
7%
Proteins
7%
Genes
7%
Interleukin-15 Receptors
6%
Multiple Myeloma
6%
KIR Receptors
6%
T-Lymphocyte Epitopes
6%
Agriculture & Biology
Human immunodeficiency virus 1
69%
Macaca mulatta
52%
Vaccinia virus
46%
vaccines
41%
Atadenovirus
29%
T-lymphocytes
29%
immunogenicity
27%
antigens
23%
Alphavirus
22%
Human immunodeficiency virus
22%
recombinant vaccines
21%
Mycobacterium bovis
20%
replicon
19%
neutralizing antibodies
18%
Bacilli
17%
antibody formation
15%
electroporation
14%
neonates
13%
Macaca
13%
vaccine development
12%
plasmids
12%
sheep
10%
immune response
9%
dosage
9%
DNA
8%
Pseudovirus
7%
Semliki Forest virus
6%
vector vaccines
5%
vaccination
5%